II. Mechanism
- 
                          Nausea and Vomiting is mediated via the physiologic Vomiting center in the Medulla- D2 Dopamine Stimulation of ChemoreceptorTrigger Zone (CTZ) in Medulla
- Many Antiemetics are dopamine Antagonists (e.g. Phenothiazines, Antipsychotic Medications)
- Serotonin Antagonists (5-HT3) are among the most commonly used Antiemetics
- Some Antihistamines (e.g. Diphenhydramine) and Anticholinergic Medications have Antiemetic properties (unclear mechanism)
 
- Stimulation of Vomiting center via three pathways- Vestibular fibers (e.g. Vertigo)
- Afferent visceral fibers (e.g. gastrointestinal)
- Fourth Ventricle (ChemoreceptorTrigger Zone)
 
III. Preparations: 5-HT3 Receptor Antagonist
- Indications- Preferred first-line Antiemetic in U.S. in most cases
- Severe Nausea and Vomiting
- Postoperative Nausea and Vomiting
- Chemotherapy-Induced Vomiting (See Nausea in Cancer)
 
- Agents
- Adverse effects- Asthenia
- Dizziness
- Constipation
- QT Prolongation (see Ondansetron)
- Serotonin Syndrome
- Use in pregnancy may be associated with increased risk of Congenital Heart Defect and Cleft Palate- (2014) Presc Lett 21(1): 5
 
 
IV. Preparations: Dopamine Antagonists - Phenothiazines
- Indications- Migraine Headaches
- Motion Sickness or Vertigo
- Chemotherapy-Induced (See Nausea in Cancer)
- Postoperative Nausea (See Nausea After Surgery)
- Severe Nausea and Vomiting
 
- Agents
- Adverse effects
V. Preparations: Dopamine Antagonists - Substituted Benzamides
- Indications
- Agents
- Adverse effects
VI. Preparations: Dopamine Antagonists - Butyrophenones
- Agents
- Indications- Chemotherapy-Induced (See Nausea in Cancer)
- Postoperative Nausea (See Nausea After Surgery)
 
- Adverse Effects- Sedation
- Agitation or restlessness
 
VII. Preparations: Sedating Antihistamines (H1 Blockers)
- Agents- Dimenhydrinate (Dramamine)
- Doxylamine (Unisom)
- Meclizine (Antivert)
- Scopolamine (Transdermal)
 
- Indications
- Adverse Effects (Anticholinergic effects)
VIII. Preparations: Neurokinin-1 Receptor Antagonist (NK1 Receptor Antagonist, Substance P Inhibitor)
- Agents
- Indications- Prevention of Nausea, Vomiting with highly emetogenic Chemotherapy- Typically used in combination with 5-HT3 Antagonists and Dexamethasone 20 mg daily
 
 
- Prevention of Nausea, Vomiting with highly emetogenic Chemotherapy
- Adverse Effects
IX. Preparations: Adjunctive and Atypical Antiemetics
- 
                          Dexamethasone
                          - Chemotherapy-Induced (See Nausea in Cancer)
 
- 
                          Cannabinoids (Dronabinol)- Chemotherapy-Induced (See Nausea in Cancer)
 
- 
                          Benzodiazepines (Lorazepam, Diazepam, Clonazepam)- Chemotherapy-Induced (See Nausea in Cancer)
- Not generally recommended
 
- 
                          Isopropyl Alcohol 70% Wipes- Fold Alcohol wipe in half and hold within a half centimeter of the nares
- Take 3 deep inhalations every 5 to 15 minutes as needed (may be repeated up to 3 times)
- May reduce the need of medications in Postoperative Nausea and Vomiting
- Pellegrini (2009) AANA J 77(4): 293-9 [PubMed]
- Cotton (2007) AANA J 75(1): 21-6 [PubMed]
 
X. Preparations: Brief list of Antiemetics for Adults
- 
                          Ondansetron (Zofran)- Dose: 4 mg (0.15mg/kg) IV (or PO) over 15 min every 4 hours as needed
 
- 
                          Metoclopramide (Reglan)- Dose: 5 to 10 mg PO/IM/IV every 6 hours as needed or 1 hour before meals and at bedtime
 
- 
                          Prochlorperazine (Compazine)- PO/IM/IV: 5-10 mg every 6-8 hours as needed
- Rectal: 25 mg PR g12h
 
- 
                          Promethazine (Phenergan)- Dose: 12.5 mg IV or 25 mg PO/IM/PR every 4 to 6 hours
 
